During late April 2016 Brant Point Partners’ portfolio holding, Acme Cryogenics, Inc., was sold to private investment firm Graham Partners. Acme Cryogenics is a leading designer and manufacturer of a full suite of critically engineered products and services for the production, distribution and storage of cryogenic liquids and industrial gases. Brant Point sourced the Acme opportunity as well as its investor partner, Gladstone Investment Corporation, a publicly traded business development company which owned a controlling interest in Acme over the course of the investment. “It was very gratifying to work with the Gladstone team and Acme management over this period of time,” said Robert Auritt, Brant Point president. Graham Partners focuses on investing in businesses with advanced industrial technologies, innovative product offerings, and strong growth potential.

ABOUT BRANT POINT PARTNERS:

Brant Point specializes in identifying transactions in the low end of the middle market for which it sources private equity firms to lead deals and alongside which Brant Point invests. The firm emphasizes business, information and healthcare services; software; niche manufacturing; and other businesses with differentiated, high-margin products and services.